Acarix and Curasight with positive study updates in a challenging week for the healthcare stocks
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week, the KPHC
18. June 2024
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week, the KPHC
The Mobility sector is the one and only this year performing exceptionally well with a 38% return year-to-date. Clean Motion
Curasight is off to a great start in 2024 with a milestone payment from Curium. After a whirlwind 2023 with
Curasight has received positive results from a Phase 2 study of uTRACE in aggressive brain cancer, validating the technology and
Danish Biotech Weekly with insights to listed Danish biotech companies. We keep you updated on their news flow including updates
In May, the current CEO of Ekobot resigned from his position, causing turmoil and a falling share price. The company
Kapital Partner performs or has within the last 12 months performed corporate finance, market relations, investor relations, Certified Adviser or other advisory activities for the following listed companies: NORD.investments, Biosergen, InterMail, Pila Pharma, Hypefactors, Curasight, Evaxion, Re-Match, Audientes, Mdundo.com, Nexcom.
Del indlægget på sociale media eller på email.